Mirador Capital Partners »

Celldex Therapeutics shares owned by Mirador Capital Partners

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Mirador Capital Partners from 13F filings

Historical chart of Mirador Capital Partners investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Mirador Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Mirador Capital Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.9M 116k 33.99
2024-06-30 $4.2M 112k 37.01
2024-03-31 $4.4M 105k 41.97
2023-12-31 $4.3M 108k 39.66
2023-09-30 $3.0M 108k 27.52
2023-06-30 $3.6M 105k 33.93
2023-03-31 $3.6M 101k 35.98
2022-12-31 $4.7M 106k 44.57
2022-09-30 $3.0M 107k 28.11
2022-06-30 $2.9M 106k 26.96
2022-03-31 $3.1M 90k 34.06
2021-12-31 $3.3M 86k 38.64
2021-09-30 $4.0M 74k 53.99
2021-06-30 $2.6M 79k 33.44
2021-03-31 $1.6M 76k 20.60
2020-12-31 $469k 27k 17.53
2020-09-30 $378k 26k 14.84
2020-06-30 $249k 19k 13.01
2020-03-31 $27k 11k 2.38